After layoffs, Casma eyes path to clinic with autophagy-boosting drug

Casma Therapeutics is unveiling its first preclinical data suggesting that a novel drug can enhance the ability of brain cells to clear out molecular garbage, an approach that it hopes will lead to new treatments …